March 15, 2021
Via: CNBCGenMark Diagnostics (GNMK) – GenMark will be bought by Swiss drugmaker Roche for $1.8 billion in cash, or $24.05 per share. Shares of the U.S.-based molecular diagnostic test maker had closed at $18.50 per share on Friday. GenMark surged 29.2% […]
March 18, 2020
Via: CNBCMGM Resorts, Marriott — Shares of casinos and hotels were in a tailspin as the industry took a massive hit due to the coronavirus outbreak. Marriott tanked nearly 30% to become the worst performer in the S&P 500 as of […]
March 26, 2024
April 4, 2024